Effects of nebulized NG-nitro-L-arginine methyl ester in patients with hepatopulmonary syndrome

Hepatology

Volumn 43, Issue 5, 2006, Pages 1084-1091

  Gómez, Federico P ^a   Barberá, Joan A ^a   Roca, Josep ^a   Burgos, Felip ^a   Gistau, Concepción ^a   Rodríguez Roisin, Robert ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ADULT; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEOXYGENATION; FEMALE; HEART OUTPUT; HEMODYNAMICS; HEPATOPULMONARY SYNDROME; HUMAN; HYPOXEMIA; LUNG GAS EXCHANGE; LUNG VASCULAR RESISTANCE; MALE; NEBULIZATION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION;

ADULT; AGED; ENZYME INHIBITORS; FEMALE; HEPATOPULMONARY SYNDROME; HUMANS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; NG-NITROARGININE METHYL ESTER; PROSPECTIVE STUDIES;

EID: 33646553635     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21141     Document Type: Article

References (34)

1. Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J 2004;24:861-880.
2. Martinez GP, Barbera JA, Visa J, Rimola A, Pare JC, Roca J, et al. Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol 2001;34:651-657.
3. Cremona G, Higenbottam TW, Mayoral V, Alexander G, Demoncheaux E, Borland C, et al. Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome. Eur Respir J 1995;8:1883-1885.
4. Fallon MB, Abrams GA, Luo B, Hou Z, Dai J, Ku DD. The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome. Gastroenterology 1997;113:606-614.
5. Luo B, Abrams GA, Fallon MB. Endothelin-1 in the rat bile duct ligation model of hepatopulmonary syndrome: correlation with pulmonary dysfunction. J Hepatol 1998;29:571-578.
6. Nunes H, Lebrec D, Mazmanian M, Capron F, Heller J, Tazi KA, et al. Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats. Am J Respir Crit Care Med 2001;164:879-885.
7. Rolla G, Brussino L, Colagrande P, Dutto L, Polizzi S, Scappaticci E, et al. Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis. HEPATOLOGY 1997;26:842-847.
8. Rolla G, Brussino L, Colagrande P, Scappaticci E, Morello M, Bergerone S, et al. Exhaled nitric oxide and impaired oxygenation in cirrhotic patients before and after liver transplantation. Ann Intern Med 1998;129:375-378.
9. Zhang M, Luo B, Chen SJ, Abrams GA, Fallon MB. Endothelin-1 stimulation of endothelial nitric oxide synthase in the pathogenesis of hepatopulmonary syndrome. Am J Physiol 1999;277:G944-G952.
10. Zhang XJ, Katsuta Y, Akimoto T, Ohsuga M, Aramaki T, Takano T. Intrapulmonary vascular dilatation and nitric oxide in hypoxemic rats with chronic bile duct ligation. J Hepatol 2003;39:724-730.
11. Berthelot P, Walker JG, Sherlock S, Reid L. Arterial changes in the lungs in cirrhosis of the liver - lung spider nevi. N Engl J Med 1966;274:291-298.
12. Hughes JM. The hepatopulmonary syndrome: No way out? Eur Respir J 2005;25:211-212.
13. Rolla G, Bucca C, Brussino L. Methylene blue in the hepatopulmonary syndrome. N Engl J Med 1994;331:1098.
14. Schenk P, Madl C, Rezaie-Majd S, Lehr S, Muller C. Methylene blue improves the hepatopulmonary syndrome. Ann Intern Med 2000;133:701-706.
15. Brussino L, Bucca C, Morello M, Scappaticci E, Mauro M, Rolla G. Effect on dyspnoea and hypoxaemia of inhaled N(G)-nitro-L-arginine methyl ester in hepatopulmonary syndrome. Lancet 2003;362:43-44.
16. Gomez FP, Barbera JA, Roca J, Iglesia R, Ribas J, Barnes PJ, et al. Effect of nitric oxide synthesis inhibition with nebulized L-NAME on ventilation-perfusion distributions in bronchial asthma. Eur Respir J 1998;12:865-871.
17. Agusti AG, Roca J, Rodriguez-Roisin R. Mechanisms of gas exchange impairment in patients with liver cirrhosis. Clin Chest Med 1996;17:49-66.
18. Gomez FP, Martinez-Palli G, Barbera JA, Roca J, Navasa M, Rodriguez-Roisin R. Gas exchange mechanism of orthodeoxia in hepatopulmonary syndrome. HEPATOLOGY 2004;40:660-666.
19. Cardus J, Burgos F, Díaz O, Roca J, Barberà JA, Marrades RM, et al. Increase in pulmonary ventilation-perfusion inequality with age in healthy individuals. Am J Respir Crit Care Med 1997;156:648-653.
20. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005;171:912-930.
21. Gomez FP, Martinez PG, Barbera JA, Roca J, Rodriguez-Roisin R. Measurement of exhaled nitric oxide in healthy subjects. Med Clin (Barc) 1998;111:1-5.
22. Fernandez J, Navasa M, Garcia-Pagan JC, Abraldes J, Jimenez W, Bosch J, et al. Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis. J Hepatol 2004;41:384-390.
23. Carter EP, Sato K, Morio Y, McMurtry IF. Inhibition of K(Ca) channels restores blunted hypoxic pulmonary vasoconstriction in rats with cirrhosis. Am J Physiol Lung Cell Mol Physiol 2000;279:L903-L910.
24. Wagner PD, Rodriguez-Roisin R. Clinical advances in pulmonary gas exchange. Am Rev Respir Dis 1991;143:883-888.
25. Rodriguez-Roisin R, Roca J, Agusti AG, Mastai R, Wagner PD, Bosch J. Gas exchange and pulmonary vascular reactivity in patients with liver cirrhosis. Am Rev Respir Dis 1987;135:1085-1092.
26. Kozma F, Johnson RA, Zhang F, Yu C, Tong X, Nasjletti A. Contribution of endogenous carbon monoxide to regulation of diameter in resistance vessels. Am J Physiol 1999;276:R1087-R1094.
27. Carter EP, Hartsfield CL, Miyazono M, Jakkula M, Morris KG Jr, McMurtry IF. Regulation of heme oxygenase-1 by nitric oxide during hepatopulmonary syndrome. Am J Physiol Lung Cell Mol Physiol 2002;283:L346-L353.
28. Zhang J, Ling Y, Luo B, Tang L, Ryter SW, Stockard CR, et al. Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome. Gastroenterology 2003;125:1441-1451.
29. Arguedas MR, Drake BB, Kapoor A, Fallon MB. Carboxyhemoglobin levels in cirrhotic patients with and without hepatopulmonary syndrome. Gastroenterology 2005;128:328-333.
30. Battaglia SE, Pretto JJ, Irving LB, Jones RM, Angus PW. Resolution of gas exchange abnormalities and intrapulmonary shunting following liver transplantation. HEPATOLOGY 1997;25:1228-1232.
31. Gomez FP, Martinez-Palli G, Garcia-Valdecasas JC, Barbera JA, Roca J, Rodriguez-Roisin R. Incomplete gas-exchange resolution after liver transplantation in hepatopulmonary syndrome [Abstract]. Eur Respir J 2003;22:19s.
32. Su Y, Cao W, Han Z, Block ER. Cigarette smoke extract inhibits angiogenesis of pulmonary artery endothelial cells: the role of calpain. Am J Physiol Lung Cell Mol Physiol 2004;287:L794-L800.
33. Rolla G, Brussino L, Dutto L, Ottobrelli A, Bucca C. Smoking and hypoxemia caused by hepatopulmonary syndrome before and after liver transplantation. HEPATOLOGY 2001;34:430-431.
34. Martinez G, Barbera JA, Navasa M, Roca J, Visa J, Rodriguez-Roisin R. Hepatopulmonary syndrome associated with cardiorespiratory disease. J Hepatol 1999;30:882-889.